24-week naturalistic observational study of efficacy of quetiapine in patients with schizophrenia or schizoaffective disorder
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2008
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms SELECT
- Sponsors AstraZeneca
- 05 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2008 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 08 Sep 2007 New trial record.